Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2006

Open Access 01-12-2006 | Review

Premature ovarian failure

Authors: Paolo Beck-Peccoz, Luca Persani

Published in: Orphanet Journal of Rare Diseases | Issue 1/2006

Login to get access

Abstract

Premature ovarian failure (POF) is a primary ovarian defect characterized by absent menarche (primary amenorrhea) or premature depletion of ovarian follicles before the age of 40 years (secondary amenorrhea). It is a heterogeneous disorder affecting approximately 1% of women <40 years, 1:10,000 women by age 20 and 1:1,000 women by age 30. The most severe forms present with absent pubertal development and primary amenorrhea (50% of these cases due to ovarian dysgenesis), whereas forms with post-pubertal onset are characterized by disappearance of menstrual cycles (secondary amenorrhea) associated with premature follicular depletion. As in the case of physiological menopause, POF presents by typical manifestations of climacterium: infertility associated with palpitations, heat intolerance, flushes, anxiety, depression, fatigue. POF is biochemically characterized by low levels of gonadal hormones (estrogens and inhibins) and high levels of gonadotropins (LH and FSH) (hypergonadotropic amenorrhea). Beyond infertility, hormone defects may cause severe neurological, metabolic or cardiovascular consequences and lead to the early onset of osteoporosis. Heterogeneity of POF is also reflected by the variety of possible causes, including autoimmunity, toxics, drugs, as well as genetic defects. POF has a strong genetic component. X chromosome abnormalities (e.g. Turner syndrome) represent the major cause of primary amenorrhea associated with ovarian dysgenesis. Despite the description of several candidate genes, the cause of POF remains undetermined in the vast majority of the cases. Management includes substitution of the hormone defect by estrogen/progestin preparations. The only solution presently available for the fertility defect in women with absent follicular reserve is ovum donation.
Literature
1.
go back to reference Santoro N: Mechanisms of premature ovarian failure. Ann Endocrinol. 2003, 64: 87-92. Santoro N: Mechanisms of premature ovarian failure. Ann Endocrinol. 2003, 64: 87-92.
2.
go back to reference Timmreck LS, Reindollar RH: Contemporary issues in primary amenorrhea. Obstet Gynecol Clin North Am. 2003, 30: 287-302. 10.1016/S0889-8545(03)00027-5.CrossRefPubMed Timmreck LS, Reindollar RH: Contemporary issues in primary amenorrhea. Obstet Gynecol Clin North Am. 2003, 30: 287-302. 10.1016/S0889-8545(03)00027-5.CrossRefPubMed
3.
go back to reference Coulam CB, Adamson SC, Annegers JF: Incidence of premature ovarian failure. Obstet Gynecol. 1986, 67: 604-606.PubMed Coulam CB, Adamson SC, Annegers JF: Incidence of premature ovarian failure. Obstet Gynecol. 1986, 67: 604-606.PubMed
4.
go back to reference Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS: Characterization of idiopathic premature ovarian failure. Fertil Steril. 1996, 64: 337-341. Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS: Characterization of idiopathic premature ovarian failure. Fertil Steril. 1996, 64: 337-341.
5.
go back to reference Cramer DW, Xu H, Harlow BL: Family history as a predictor of early menopause. Fertil Steril. 1995, 64: 740-745.PubMed Cramer DW, Xu H, Harlow BL: Family history as a predictor of early menopause. Fertil Steril. 1995, 64: 740-745.PubMed
6.
go back to reference Torgerson DJ, Thomas RE, Reid DM: Mothers and daughters menopausal ages: is there a link?. Eur J Obstet Gynecol Reprod Biol . 1997, 74: 63-66. 10.1016/S0301-2115(97)00085-7.CrossRefPubMed Torgerson DJ, Thomas RE, Reid DM: Mothers and daughters menopausal ages: is there a link?. Eur J Obstet Gynecol Reprod Biol . 1997, 74: 63-66. 10.1016/S0301-2115(97)00085-7.CrossRefPubMed
7.
go back to reference Simpson JL, Rajkovic A: Ovarian differentiation and gonadal failure. Am J Med Genet. 1999, 89: 186-200. 10.1002/(SICI)1096-8628(19991229)89:4<186::AID-AJMG3>3.0.CO;2-5.CrossRefPubMed Simpson JL, Rajkovic A: Ovarian differentiation and gonadal failure. Am J Med Genet. 1999, 89: 186-200. 10.1002/(SICI)1096-8628(19991229)89:4<186::AID-AJMG3>3.0.CO;2-5.CrossRefPubMed
8.
go back to reference Sherman SL: Premature ovarian failure in the fragile X syndrome. Am J Med Genet. 2000, 97: 189-194. 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J.CrossRefPubMed Sherman SL: Premature ovarian failure in the fragile X syndrome. Am J Med Genet. 2000, 97: 189-194. 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J.CrossRefPubMed
9.
go back to reference Sybert PV, McCauley E: Turner's syndrome. N Engl J Med. 2004, 351: 1227-1238. 10.1056/NEJMra030360.CrossRefPubMed Sybert PV, McCauley E: Turner's syndrome. N Engl J Med. 2004, 351: 1227-1238. 10.1056/NEJMra030360.CrossRefPubMed
10.
go back to reference Goswami D, Conway GS: Premature ovarian failure. Hum Reprod Update. 2005, 11: 391-410. 10.1093/humupd/dmi012.CrossRefPubMed Goswami D, Conway GS: Premature ovarian failure. Hum Reprod Update. 2005, 11: 391-410. 10.1093/humupd/dmi012.CrossRefPubMed
11.
go back to reference Achermann JC, Ozisik G, Meeks JJ, Jameson JL: Perspective: genetic causes of human reproductive diseases. J Clin Endocrinol Metab. 2002, 87: 2447-2454. 10.1210/jc.87.6.2447.CrossRefPubMed Achermann JC, Ozisik G, Meeks JJ, Jameson JL: Perspective: genetic causes of human reproductive diseases. J Clin Endocrinol Metab. 2002, 87: 2447-2454. 10.1210/jc.87.6.2447.CrossRefPubMed
12.
go back to reference Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, Kaskikari R, Sankila EM, Lehvaslaiho H, Engel AR, Nieschlag E, Huhtaniemi I, de la Chapelle A: Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995, 82: 959-568. 10.1016/0092-8674(95)90275-9.CrossRefPubMed Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, Kaskikari R, Sankila EM, Lehvaslaiho H, Engel AR, Nieschlag E, Huhtaniemi I, de la Chapelle A: Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995, 82: 959-568. 10.1016/0092-8674(95)90275-9.CrossRefPubMed
13.
go back to reference Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, Matuchansky C, Milgrom E, Kuttenn F, Misrahi M: A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest. 1998, 102: 1352-1359.PubMedCentralCrossRefPubMed Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, Matuchansky C, Milgrom E, Kuttenn F, Misrahi M: A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest. 1998, 102: 1352-1359.PubMedCentralCrossRefPubMed
14.
go back to reference De Baere E, Beysen D, Oley C, Lorenz B, Cocquet J, De Sutter P, Devriendt K, Dixon M, Fellous M, Fryns JP, Garza A, Jonsrud C, Koivisto PA, Krause A, Leroy BP, Meire F, Plomp A, Van Maldergem L, De Paepe A, Veitia R, Messiaen L: FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. Am J Hum Genet. 2003, 72: 478-487. 10.1086/346118.PubMedCentralCrossRefPubMed De Baere E, Beysen D, Oley C, Lorenz B, Cocquet J, De Sutter P, Devriendt K, Dixon M, Fellous M, Fryns JP, Garza A, Jonsrud C, Koivisto PA, Krause A, Leroy BP, Meire F, Plomp A, Van Maldergem L, De Paepe A, Veitia R, Messiaen L: FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. Am J Hum Genet. 2003, 72: 478-487. 10.1086/346118.PubMedCentralCrossRefPubMed
15.
go back to reference Di Pasquale E, Beck-Peccoz P, Persani L: Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet. 2004, 75: 106-111. 10.1086/422103.PubMedCentralCrossRefPubMed Di Pasquale E, Beck-Peccoz P, Persani L: Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet. 2004, 75: 106-111. 10.1086/422103.PubMedCentralCrossRefPubMed
16.
go back to reference Shimasaki S, Moore RK, Otsuka F, Erickson GF: The bone morphogenetic protein system in mammalian reproduction. Endocr Rev. 2004, 25: 72-101. 10.1210/er.2003-0007.CrossRefPubMed Shimasaki S, Moore RK, Otsuka F, Erickson GF: The bone morphogenetic protein system in mammalian reproduction. Endocr Rev. 2004, 25: 72-101. 10.1210/er.2003-0007.CrossRefPubMed
17.
go back to reference Harris SE, Chand AL, Winship IM, Gersak K, Aittomaki K, Shelling AN: Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod. 2002, 8: 729-733. 10.1093/molehr/8.8.729.CrossRefPubMed Harris SE, Chand AL, Winship IM, Gersak K, Aittomaki K, Shelling AN: Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod. 2002, 8: 729-733. 10.1093/molehr/8.8.729.CrossRefPubMed
18.
go back to reference Bodega B, Porta C, Crosignani PG, Ginelli E, Marozzi A: Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure. Mol Hum Reprod. 2004, 10: 555-557. 10.1093/molehr/gah078.CrossRefPubMed Bodega B, Porta C, Crosignani PG, Ginelli E, Marozzi A: Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure. Mol Hum Reprod. 2004, 10: 555-557. 10.1093/molehr/gah078.CrossRefPubMed
19.
go back to reference Touraine P, Beau I, Gougeon A, Meduri G, Desroches A, Pichard C, Detoeuf M, Paniel B, Prieur M, Zorn JR, Milgrom E, Kuttenn F, Misrahi M: New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol Endocrinol. 1999, 13: 1844-1854. 10.1210/me.13.11.1844.CrossRefPubMed Touraine P, Beau I, Gougeon A, Meduri G, Desroches A, Pichard C, Detoeuf M, Paniel B, Prieur M, Zorn JR, Milgrom E, Kuttenn F, Misrahi M: New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol Endocrinol. 1999, 13: 1844-1854. 10.1210/me.13.11.1844.CrossRefPubMed
20.
go back to reference Arnhold IJ, Latronico AC, Batista MC, Izzo CR, Mendonca BB: Clinical features of women with resistance to luteinizing hormone. Clin Endocrinol (Oxf). 1999, 51: 701-707. 10.1046/j.1365-2265.1999.00863.x.CrossRef Arnhold IJ, Latronico AC, Batista MC, Izzo CR, Mendonca BB: Clinical features of women with resistance to luteinizing hormone. Clin Endocrinol (Oxf). 1999, 51: 701-707. 10.1046/j.1365-2265.1999.00863.x.CrossRef
21.
go back to reference Hickey M, Balen A: Menstrual disorders in adolescence: investigation and management. Hum Reprod Update. 2003, 9: 493-504. 10.1093/humupd/dmg038.CrossRefPubMed Hickey M, Balen A: Menstrual disorders in adolescence: investigation and management. Hum Reprod Update. 2003, 9: 493-504. 10.1093/humupd/dmg038.CrossRefPubMed
22.
go back to reference Meduri G, Touraine P, Beau I, Lahuna O, Desroches A, Vacher-Lavenu MC, Kuttenn F, Misrahi M: Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J Clin Endocrinol Metab. 2003, 88: 3491-3498. 10.1210/jc.2003-030217.CrossRefPubMed Meduri G, Touraine P, Beau I, Lahuna O, Desroches A, Vacher-Lavenu MC, Kuttenn F, Misrahi M: Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J Clin Endocrinol Metab. 2003, 88: 3491-3498. 10.1210/jc.2003-030217.CrossRefPubMed
23.
go back to reference Weinstein LS, Liu J, Sakamoto A, Xie T, Chen M: Minireview: GNAS: normal and abnormal functions. Endocrinology. 2004, 145: 5459-5464. 10.1210/en.2004-0865.CrossRefPubMed Weinstein LS, Liu J, Sakamoto A, Xie T, Chen M: Minireview: GNAS: normal and abnormal functions. Endocrinology. 2004, 145: 5459-5464. 10.1210/en.2004-0865.CrossRefPubMed
24.
go back to reference Chiauzzi VA, Bussmann L, Calvo JC, Sundblad V, Charreau EH: Circulating immunoglobulins that inhibit the binding of follicle stimulating hormone receptor: a putative diagnostic role in resistant ovary syndrome. Clin Endocrinol (Oxf). 2004, 61: 46-54. 10.1111/j.1365-2265.2004.02054.x.CrossRef Chiauzzi VA, Bussmann L, Calvo JC, Sundblad V, Charreau EH: Circulating immunoglobulins that inhibit the binding of follicle stimulating hormone receptor: a putative diagnostic role in resistant ovary syndrome. Clin Endocrinol (Oxf). 2004, 61: 46-54. 10.1111/j.1365-2265.2004.02054.x.CrossRef
Metadata
Title
Premature ovarian failure
Authors
Paolo Beck-Peccoz
Luca Persani
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2006
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/1750-1172-1-9

Other articles of this Issue 1/2006

Orphanet Journal of Rare Diseases 1/2006 Go to the issue